Legal Due Diligence for Private Equity Investing in Kenyan Hospital Groups

A private equity fund evaluating a Kenyan hospital group is buying more than beds and a brand. It is buying a licensed operating entity, a set of individually licensed clinicians, a claims relationship with the Social Health Authority, a bank of patient health records, and a workforce governed by rules that do not map cleanly onto the transaction structures a fund would use elsewhere. This article sets out the due diligence hospital groups specific points that matter for a Kenyan healthcare target, rather than the general corporate diligence any deal would already cover.

Due diligence hospital groups face: competition clearance at a lower threshold than the general merger rule

The Competition Authority of Kenya’s Consolidated Guidelines on the Substantive Assessment of Mergers set a healthcare-specific notification threshold that is materially lower than the general one. Outside sensitive sectors, mandatory notification applies where the combined turnover or asset value of the merging parties reaches at least KES 1 billion and the target’s own turnover exceeds KES 100 million. For healthcare, that threshold drops to a combined turnover or asset value of at least KES 500 million where the target’s turnover exceeds KES 50 million, and transactions between KES 50 million and KES 500 million combined may apply for a discretionary exclusion rather than qualifying automatically. A fund used to sector-neutral thresholds elsewhere should not assume a Kenyan hospital deal falls below the notification line simply because it would in a general merger. Where notification is required, the Authority’s own published timeline runs to sixty days from a complete filing, extendable by a further sixty days if it requests more information, with a shorter fourteen-day turnaround on exclusion applications.

A hospital’s operating licence does not automatically transfer with a change of ownership

Section 89 of the Health Act, 2017 requires private health facilities to be licensed by the appropriate regulatory bodies but leaves the mechanics to subsidiary regulation. The operative rule sits in the Medical Practitioners and Dentists (Medical Institutions) Rules: rule 5(7) states plainly that no licence may be transferred under those Rules, and licensing is institutional, issued to the specific operating entity rather than to whoever happens to own it. In practice, this means a share acquisition, where the licensed company itself does not change, leaves the existing licence intact as a matter of law, while an asset sale, where operations move to a new entity, requires that new entity to obtain its own licence from scratch. Kenya’s Medical Practitioners and Dentists Council also runs its own administrative process for a change of a facility’s particulars or ownership, which functions in practice as a fresh review even where the underlying corporate shell has not changed. A fund should confirm directly with the Council how it intends to treat the specific deal structure under consideration, rather than assuming a share deal avoids regulatory re-engagement entirely.

Practitioner registration travels with the individual, not the facility

Clinicians hold their own registration under the Medical Practitioners and Dentists Act, separately from the facility’s institutional licence, and a change in who owns the facility does not itself put an individual practitioner’s registration at risk. That separation cuts both ways for diligence purposes: it means the deal structure itself is not a threat to clinical staff’s ability to practise, but it also means facility-level licensing checks tell a fund nothing about whether individual clinicians are in fact currently registered and in good standing, which is a distinct check worth running against the Council’s own register before completion.

SHA empanelment and claims history is a genuine diligence blind spot

Sections 33 and 34 of the Social Health Insurance Act, 2023 govern how a facility becomes and remains empaneled, and the Authority can terminate a facility’s contract for non-compliance. The Act does not contain an explicit provision addressing what happens to empanelment status, or to disputed or rejected claims, when the facility changes hands. As a matter of general Kenyan company law, a share acquisition leaves the target’s legal personality unchanged, so its liabilities, including any disputed or unresolved SHA claims, continue automatically with it; an asset sale, by contrast, generally leaves those liabilities with the seller unless the buyer expressly agrees to assume them. Because the Act itself is silent on the empanelment-specific question, a fund should independently confirm the target’s current empanelment status and outstanding claims position directly with the Authority before completion, rather than relying on the general successor-liability principle to cover a scenario the statute does not actually address.

Patient records make data protection diligence non-negotiable

The Office of the Data Protection Commissioner’s own guidance on health data confirms that patient health information is sensitive personal data, and that healthcare entities face mandatory registration with the ODPC regardless of size, since healthcare is treated as a non-exempt sector. High-risk processing requires a documented data protection impact assessment, breach notification runs on a seventy-two-hour clock, and any processor relationship needs a written agreement. Diligence should confirm the target’s current ODPC registration certificate and ask directly about any breach history, since a gap here is not merely a compliance footnote in a healthcare deal; it is a direct line to the value of the patient relationships being acquired.

Employment: Kenya has no TUPE, so the deal structure matters

The Employment Act, 2007 contains no transfer-of-undertakings provision equivalent to the UK’s TUPE regime. A share acquisition does not disturb existing employment contracts, because the employing entity does not change. An asset sale that moves operations to a new employing entity is a different matter: absent the employees’ consent to have their contracts novated to the buyer, the change can trigger the redundancy-style notice, consultation, and severance obligations set out in section 40. A fund weighing a share deal against an asset deal should treat this as one of the concrete cost and risk differences between the two structures, not a formality to handle after signing.